One Sample, One Shot - Evaluation of sample preparation protocols for the mass spectrometric proteome analysis of human bile fluid without extensive fractionation

Farina, 2014, Proximal fluid proteomics for the discovery of digestive cancer biomarkers, Biochim. Biophys. Acta, 1844, 988, 10.1016/j.bbapap.2013.10.011 Farina, 2014, Bile proteome in health and disease, Compr. Physiol., 4, 91, 10.1002/cphy.c130016 Yamazaki, 1988, Biliary proteins: assessment of quantitative techniques and comparison in gallstone and nongallstone subjects, J. Lipid Res., 29, 1055, 10.1016/S0022-2275(20)38469-8 Farina, 2009, Proteomic analysis of human bile and potential applications for cancer diagnosis, Expert Rev. Proteomics, 6, 285, 10.1586/epr.09.12 Farina, 2011, A step further in the analysis of human bile proteome, J. Proteome Res., 10, 2047, 10.1021/pr200011b Farid, 2011, Shotgun proteomics of human bile in hilar cholangiocarcinoma, Proteomics, 11, 2134, 10.1002/pmic.201000653 Barbhuiya, 2011, Comprehensive proteomic analysis of human bile, Proteomics, 11, 4443, 10.1002/pmic.201100197 Megger, 2013, Label-free quantification in clinical proteomics, Biochim. Biophys. Acta, 1834, 1581, 10.1016/j.bbapap.2013.04.001 Megger, 2013, Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study, Mol. Cell. Proteomics, 12, 2006, 10.1074/mcp.M113.028027 Reis, 2015, A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumors, Biochim. Biophys. Acta, 1854, 641, 10.1016/j.bbapap.2014.10.024 Padden, 2014, Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinoma, Mol. Cell. Proteomics, 13, 2661, 10.1074/mcp.M113.034942 Megger, 2014, Comparison of label-free and label-based strategies for proteome analysis of hepatoma cell lines, Biochim. Biophys. Acta, 1844, 967, 10.1016/j.bbapap.2013.07.017 Berthold, 2008, KNIME: The Konstanz Information Miner, 319 Martens, 2011, mzML--a community standard for mass spectrometry data, Mol. Cell. Proteomics, 10, 10.1074/mcp.R110.000133 Kessner, 2008, ProteoWizard: open source software for rapid proteomics tools development, Bioinformatics, 24, 2534, 10.1093/bioinformatics/btn323 Weisser, 2013, An automated pipeline for high-throughput label-free quantitative proteomics, J. Proteome Res., 12, 1628, 10.1021/pr300992u Mayer, 2015, ProCon - PROteomics CONversion tool, J. Proteomics, 129, 56, 10.1016/j.jprot.2015.06.015 Huang da, 2009, Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists, Nucleic Acids Res., 37, 1, 10.1093/nar/gkn923 Huang da, 2009, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nat. Protoc., 4, 44, 10.1038/nprot.2008.211 Shevchenko, 2006, In-gel digestion for mass spectrometric characterization of proteins and proteomes, Nat. Protoc., 1, 2856, 10.1038/nprot.2006.468 Fang, 2015, Matrix effects break the LC behavior rule for analytes in LC-MS/MS analysis of biological samples, Exp. Biol. Med. (Maywood), 240, 488, 10.1177/1535370214554545 Van Eeckhaut, 2009, Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects, J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 877, 2198, 10.1016/j.jchromb.2009.01.003 Bantscheff, 2007, Quantitative mass spectrometry in proteomics: a critical review, Anal. Bioanal. Chem., 389, 1017, 10.1007/s00216-007-1486-6 Neilson, 2011, Less label, more free: approaches in label-free quantitative mass spectrometry, Proteomics, 11, 535, 10.1002/pmic.201000553 Bantscheff, 2012, Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present, Anal. Bioanal. Chem., 404, 939, 10.1007/s00216-012-6203-4 Sandra, 2008, Highly efficient peptide separations in proteomics Part 1. Unidimensional high performance liquid chromatography, J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 866, 48, 10.1016/j.jchromb.2007.10.034 Sandra, 2009, Highly efficient peptide separations in proteomics. Part 2: bi- and multidimensional liquid-based separation techniques, J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 877, 1019, 10.1016/j.jchromb.2009.02.050 Naboulsi, 2016, Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular Carcinoma, J. Proteome Res., 15, 38, 10.1021/acs.jproteome.5b00420 Bracht, 2015, Analysis of disease-associated protein expression using quantitative proteomics-fibulin-5 is expressed in association with hepatic fibrosis, J. Proteome Res., 14, 2278, 10.1021/acs.jproteome.5b00053 Chambers, 2015, Multiple Reaction Monitoring Enables Precise Quantification of 97 Proteins in Dried Blood Spots, Mol. Cell. Proteomics, 14, 3094, 10.1074/mcp.O115.049957 Percy, 2014, Multiplexed MRM with Internal Standards for Cerebrospinal Fluid Candidate Protein Biomarker Quantitation, J. Proteome Res., 10.1021/pr500317d Chambers, 2014, MRM for the verification of cancer biomarker proteins: recent applications to human plasma and serum, Expert Rev. Proteomics, 11, 137, 10.1586/14789450.2014.877346 Voigtlander, 2015, Endoscopic diagnosis of cholangiocarcinoma: From endoscopic retrograde cholangiography to bile proteomics, Best Pract. Res. Clin. Gastroenterol., 29, 267, 10.1016/j.bpg.2015.02.005 Lankisch, 2011, Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis, Hepatology, 53, 875, 10.1002/hep.24103